查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587400

病理实验室市场规模、份额、趋势分析报告：按类型、按实验室服务、按最终用途、按地区、细分市场预测，2025-2030 年

Pathology Laboratories Market Size, Share & Trends Analysis Report By Type, By Testing Services, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

病理实验室市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球病理实验室市场规模将达到6,122.2亿美元，2025年至2030年复合年增长率为8.1%。

推动该行业的关键因素包括预期寿命的延长、开发中国家医疗保健基础设施的改善、报销的增加以及定期体检需求的增加。

此外，技术进步正在改变诊断的动态。创新技术使即时检测 (POCT) 设备变得便携，并改进了采样技术，使诊断服务更加便捷和高效。预计多项进步将透过品质、速度、效率和扩充性来指导患者照护，从而改变整个行业。医疗保健系统逐渐强调病理和诊断实验室的重要性，它们不仅可以更快、更准确地监测患者，还可以协助医生做出推论和诊断，成为更大的临床决策引擎。

COVID-19 大流行导致对病理学和诊断实验室的需求增加，因为在大流行期间需要对 COVID-19 进行检测。 COVID-19 感染的激增导致资金和测试的增加，从而促进了整体市场的成长。例如，2020 年 9 月，美国国立卫生研究院 (NIH) 宣布，Maxim Biomedical Inc. 将扩大对一套新的 COVID-19 检测技术的製造支持，作为倡议的一部分，宣布投入129.3美元。

病理实验室市场报告亮点

  • 按类型划分，医院诊断实验室将在 2024 年占据市场主导地位。这是因为医院提供的先进测试已成为复杂诊断的最佳解决方案。
  • 根据最终用途，医师转诊将在 2024 年占据市场主导地位。由于监控个人健康和保健的自我认知增强，预计步入式客户和企业客户将出现良好的成长。
  • 由于美国最流行的疾病，预计美国对心血管健康诊断的需求将会很高。
  • 预计欧洲在预测期内将出现较大的复合年增长率。根据世界癌症研究基金会的数据，丹麦是全球癌症盛行率最高的国家。
  • 在这个市场上，主要企业最近开展了多个联合研究项目，旨在提高服务付加并扩大研究范围。例如，2022年7月，Unilab宣布与Subtle Medical建立合作关係，成为第一家采用该公司基于人工智慧的MRI技术进行高品质、快速MRI的诊断公司。该解决方案将首先在瑞典推出。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章病理实验室市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 病理实验室市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章病理实验室市场：类型估计和趋势分析

  • 细分仪表板
  • 病理实验室市场：类型变异分析
  • 病理实验室市场：按类型分類的展望
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 独立实验室
  • 诊断专业

第五章病理实验室市场：实验室服务的估计和趋势分析

  • 细分仪表板
  • 病理实验室市场：实验室服务波动分析
  • 病理实验室市场：实验室服务展望
  • 2018-2030年市场规模、预测及趋势分析
  • 一般生理和实验室测试
  • 影像检查和放射学检查
  • 困难的考验
  • COVID-19 测试

第六章病理实验室市场：最终用途估计和趋势分析

  • 细分仪表板
  • 病理实验室市场：最终用途变异分析
  • 病理实验室市场：最终用途展望
  • 2018-2030年市场规模、预测及趋势分析
  • 医生介绍
  • 步入式
  • 公司

第七章病理实验室市场：区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 2024 年企业市场占有率分析
  • 主要企业简介
    • Quest Diagnostics Incorporated
    • Eurofins Scientific
    • Laboratory Corporation of America Holdings
    • Exact Sciences Laboratories LLC
    • Spectra Laboratories
    • SYNLAB International GmbH
    • Sonic Healthcare Limited
    • DR Lal Path Labs.
    • Metropolis Healthcare
    • Kingmed Diagnostics
Product Code: GVR-4-68039-987-6

Pathology Laboratories Market Growth & Trends:

The global pathology laboratories market size is estimated to reach USD 612.22 billion by 2030, registering a CAGR of 8.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors driving the industry include increasing life expectancy, the development of healthcare infrastructure in developing nations, favoring reimbursement, and rising demand for routine medical check-ups.

In addition, the advancement of technology is altering the dynamics of diagnosis. Innovative technologies have made Point of Care Testing(POCT) devices portable and improved sampling techniques, making diagnostic services more accessible and efficient. Several advancements are expected to transform the industry by steering patient care through quality, speed, efficiency, and scalability. The healthcare system is progressively emphasizing the importance of pathological & diagnostic labs in becoming a greater clinical decision-making engine, assisting physicians in making inferences and diagnosing as well as monitoring patients more quickly and accurately.

The COVID-19 pandemic has resulted in higher demand for pathology/diagnostic labs as the testing for COVID-19 was necessary during the pandemic. The rapid rise of COVID-19 infections has resulted in increased funding and testing, which has boosted the overall market growth. For instance, the (NIH) National Institutes of Health in the United States announced in September 2020 that it would grant USD 129.3 million in funding to nine organizations including, Maxim Biomedical Inc., MatMaCorp, MicroGEM International, & others, for scaling-up manufacturing assistance to a new set of COVID-19 testing technologies as component of its initiative to boost diagnostics in the region.

Pathology Laboratories Market Report Highlights:

  • Based on type, hospital-based diagnostic labs dominated the market during the year 2024. This can be attributed to the advanced tests available at hospitals, making them the only best solution for complex diagnosis
  • Based on the end use, physician referrals dominated the market in 2024. Walk-in and corporate clients are expected to witness lucrative growth due to increased self-awareness for monitoring health and wellness among individuals
  • U.S. is expected to have a high demand for the diagnosis of cardiovascular health as a result of the most prominent disease in the U.S.
  • Europe is expected to have a significant CAGR during the forecast period. Denmark has the highest prevalence of cancer globally in terms of cancer prevalence as per the World Cancer Research Fund International
  • The market is witnessing multiple collaborations in recent times with the key players aiming at adding value to their services & expanding their research. For Instance, in July 2022, Unilabs announced a partnership with Subtle Medical, to be the first diagnostic company to adopt their AI-based MRI technology for high-quality & quick MRI. The solution will be first launched in Sweden.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Testing Services
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Pathology Laboratories Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Improving healthcare infrastructure in developing countries
      • 3.2.1.2. Increasing demand for regular general health check-ups
      • 3.2.1.3. Gowning reimbursement for diagnostics services
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Affordability for high-end molecular diagnostics
      • 3.2.2.2. Shortage of skilled workforce
  • 3.3. Pathology Laboratories Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Pathology Laboratories Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pathology Laboratories Market: Type Movement Analysis
  • 4.3. Pathology Laboratories Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Hospital Based
    • 4.5.1. Hospital Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Standalone Labs
    • 4.6.1. Standalone Labs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Diagnostic Chains
    • 4.7.1. Diagnostic Chains Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pathology Laboratories Market: Testing Services Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pathology Laboratories Market: Testing Services Movement Analysis
  • 5.3. Pathology Laboratories Market by Testing Services Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. General Physiological & Clinical Tests
    • 5.5.1. General Physiological & Clinical Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Imaging & Radiology Tests
    • 5.6.1. Imaging & Radiology Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Esoteric Tests
    • 5.7.1. Esoteric Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. COVID-19 Tests
    • 5.8.1. COVID-19 Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pathology Laboratories Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pathology Laboratories Market: End Use Movement Analysis
  • 6.3. Pathology Laboratories Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Physician Referrals
    • 6.5.1. Physician Referrals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Walk-Ins
    • 6.6.1. Walk-Ins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Corporate
    • 6.7.1. Corporate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pathology Laboratories Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Quest Diagnostics Incorporated
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Eurofins Scientific
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Laboratory Corporation of America Holdings
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Exact Sciences Laboratories LLC
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Spectra Laboratories
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. SYNLAB International GmbH
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Sonic Healthcare Limited
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. DR Lal Path Labs.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Metropolis Healthcare
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Kingmed Diagnostics
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 4. Global Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 5. Global Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 6. North America Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 7. North America Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 8. North America Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 11. U.S. Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 12. Canada Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 13. Canada Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 14. Canada Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 15. Mexico Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 16. Mexico Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 17. Mexico Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 18. Europe Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 19. Europe Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 20. Europe Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 21. UK Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 22. UK Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 23. UK Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 24. Germany Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 25. Germany Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 26. Germany Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 27. France Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 28. France Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 29. France Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. Italy Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 31. Italy Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 32. Italy Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 33. Spain Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 34. Spain Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 35. Spain Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 36. Denmark Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 37. Denmark Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 38. Denmark Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 39. Sweden Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 40. Sweden Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 41. Sweden Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Norway Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Norway Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 44. Norway Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 48. Japan Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 49. Japan Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 50. Japan Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 51. China Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 52. China Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 53. China Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. India Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 55. India Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 56. India Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 57. Australia Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 58. Australia Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 59. Australia Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 60. South Korea Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 61. South Korea Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 62. South Korea Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 63. Thailand Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 64. Thailand Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 65. Thailand Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 66. Latin America Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 67. Latin America Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 68. Latin America Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 69. Brazil Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 70. Brazil Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 71. Brazil Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 72. Argentina Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 73. Argentina Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 74. Argentina Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 77. Middle East & Africa Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 78. South Africa Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 79. South Africa Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 80. South Africa Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 84. UAE Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 85. UAE Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 86. UAE Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Kuwait Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 88. Kuwait Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 89. Kuwait Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Pathology Laboratories market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Pathology Laboratories market, Type outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 12 Pathology Laboratories market, Testing Services outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 13 Pathology Laboratories market, End-Use outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 14 Hospital Based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Imaging Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Respiratory Measurement Devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Other Hospital Based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Standalone Labs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Diagnostic Chains market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 General Physiological & Clinical Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Imaging & Radiology Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Esoteric Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 COVID-19 Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Physician Referrals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Walk-ins market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Corporate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 North America Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 US Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 List of key emerging company's/Allergen disruptors/innovators